Bionic chips to replace animal testing for drug development

Bionic chips to replace animal testing for drug development


Bionic chips to replace animal testing for drug development
‘We are now able to insert microsensors that offer us real-time information on how drugs work and when they stop working.’
March 9, 2021, 3:56 pm
Prof. Yaakov Nahmias, right, and team member Aaron Cohen at Hebrew University’s Grass Center for Bioengineering. Photo by Daniel Hanoch
“Human-on-a-chip” technology for rapid drug development without animal experimentation has been introduced by researchers led by Prof. Yaakov Nahmias, director of the Grass Center for Bioengineering at the Hebrew University of Jerusalem and founder of Tissue Dynamics.
The technology itself isn’t new, but Nahmias’s team took it to a new level as described in

Related Keywords

Jerusalem , Israel General , Israel , Yaakov Nahmias , Hebrew University Of Jerusalem , Grass Center , Hebrew University , Science Transitional Medicine , News , Health , Drug Development , , ஏருசலேம் , இஸ்ரேல் ஜநரல் , இஸ்ரேல் , யாகோவ் நாஹ்மியச் , ஹீப்ரு பல்கலைக்கழகம் ஆஃப் ஏருசலேம் , புல் மையம் , ஹீப்ரு பல்கலைக்கழகம் , அறிவியல் இடைநிலை மருந்து , செய்தி , ஆரோக்கியம் , மருந்து வளர்ச்சி ,

© 2025 Vimarsana